243 related articles for article (PubMed ID: 9146668)
1. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD
J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD
Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292
[TBL] [Abstract][Full Text] [Related]
3. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.
Nistér M; Libermann TA; Betsholtz C; Pettersson M; Claesson-Welsh L; Heldin CH; Schlessinger J; Westermark B
Cancer Res; 1988 Jul; 48(14):3910-8. PubMed ID: 2454731
[TBL] [Abstract][Full Text] [Related]
4. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
5. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
6. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma.
Walker C; Everitt J; Freed JJ; Knudson AG; Whiteley LO
Cancer Res; 1991 Jun; 51(11):2973-8. PubMed ID: 2032234
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
[TBL] [Abstract][Full Text] [Related]
9. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
[TBL] [Abstract][Full Text] [Related]
10. Tumor secretion of growth factors.
Daughaday WH; Deuel TF
Endocrinol Metab Clin North Am; 1991 Sep; 20(3):539-63. PubMed ID: 1718747
[TBL] [Abstract][Full Text] [Related]
11. Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha.
Atlas I; Mendelsohn J; Baselga J; Fair WR; Masui H; Kumar R
Cancer Res; 1992 Jun; 52(12):3335-9. PubMed ID: 1596891
[TBL] [Abstract][Full Text] [Related]
12. Effects of TNF-alpha and retinoic acid on the proliferation of the clear cell and chromophilic types of human renal cell carcinoma in vitro.
Gerharz CD; Ramp U; Reinecke P; Ressler U; Dienst M; Marx N; Friebe U; Engers R; Pollow K; Gabbert HE
Anticancer Res; 1996; 16(4A):1633-41. PubMed ID: 8712681
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
Kominsky SL; Doucet M; Brady K; Weber KL
J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
Reynolds RK; Hu C; Baker VV
Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691
[TBL] [Abstract][Full Text] [Related]
15. Growth modulation by epidermal growth factor (EGF) in human colonic carcinoma cells: constitutive expression of the human EGF gene.
Huang SA; Lin PF; Fan D; Price JE; Trujillo JM; Chakrabarty S
J Cell Physiol; 1991 Aug; 148(2):220-7. PubMed ID: 1880151
[TBL] [Abstract][Full Text] [Related]
16. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha.
Rodeck U; Williams N; Murthy U; Herlyn M
J Cell Biochem; 1990 Oct; 44(2):69-79. PubMed ID: 2250044
[TBL] [Abstract][Full Text] [Related]
18. Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.
Kundu SD; Kim IY; Zelner D; Janulis L; Goodwin S; Engel JD; Lee C
J Urol; 1998 Nov; 160(5):1883-8. PubMed ID: 9783979
[TBL] [Abstract][Full Text] [Related]
19. Modulation of epidermal growth factor receptor gene expression by transforming growth factor-beta in a human breast carcinoma cell line.
Fernandez-Pol JA; Klos DJ; Hamilton PD; Talkad VD
Cancer Res; 1987 Aug; 47(16):4260-5. PubMed ID: 3496959
[TBL] [Abstract][Full Text] [Related]
20. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
